Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Turecek

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Thrombosis and Haemostasis|November 2, 1999
Phenotypic expression of murine hemophiliaE M Muchitsch, P L Turecek, K Zimmermann, et al.
FEBS Letters|November 20, 1995
Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co-expressing recombinant furinB E Fischer, U Schlokat, A Mitterer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 3, 2014
The biological efficacy profile of BAX 855, a PEGylated recombinant factor VIII moleculeL A Valentino, L Cong, C Enockson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2016
A world-wide survey and field study in clinical haemostasis laboratories to evaluate FVIII:C activity assay variability of ADYNOVATE and OBIZUR in comparison with ADVATEP L Turecek, S Romeder-Finger, C Apostol, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 11, 1998
Factor X Frankfurt I: molecular and functional characterization of a hereditary factor X deficiency (Gla+25 to Lys)I M Nöbauer-Huhmann, W Höller, B Krinninger, et al.
Seminars in Thrombosis and Hemostasis|September 8, 2001
Recombinant von Willebrand factor: preclinical developmentB Plaimauer, U Schlokat, P L Turecek, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2003
Monitoring the bioavailability of FEIBA with a thrombin generation assayK Váradi, C Negrier, E Berntorp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Continuous infusion of FVIII and FIX concentrates: in vitro analysis of clinically relevant parametersK B Thomas, W Urbancik, P L Turecek, et al.
Journal of Thrombosis and Haemostasis : JTH|May 9, 2009
Species-dependent variability of ADAMTS13-mediated proteolysis of human recombinant von Willebrand factorK Varadi, H Rottensteiner, S Vejda, et al.
Thrombosis and Haemostasis|August 3, 1992
High level expression of active human prothrombin in a vaccinia virus expression systemF G Falkner, P L Turecek, R T MacGillivray, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Thrombosis and Haemostasis|November 2, 1999
Phenotypic expression of murine hemophiliaE M Muchitsch, P L Turecek, K Zimmermann, et al.
FEBS Letters|November 20, 1995
Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co-expressing recombinant furinB E Fischer, U Schlokat, A Mitterer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 3, 2014
The biological efficacy profile of BAX 855, a PEGylated recombinant factor VIII moleculeL A Valentino, L Cong, C Enockson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2016
A world-wide survey and field study in clinical haemostasis laboratories to evaluate FVIII:C activity assay variability of ADYNOVATE and OBIZUR in comparison with ADVATEP L Turecek, S Romeder-Finger, C Apostol, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 11, 1998
Factor X Frankfurt I: molecular and functional characterization of a hereditary factor X deficiency (Gla+25 to Lys)I M Nöbauer-Huhmann, W Höller, B Krinninger, et al.
Seminars in Thrombosis and Hemostasis|September 8, 2001
Recombinant von Willebrand factor: preclinical developmentB Plaimauer, U Schlokat, P L Turecek, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2003
Monitoring the bioavailability of FEIBA with a thrombin generation assayK Váradi, C Negrier, E Berntorp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Continuous infusion of FVIII and FIX concentrates: in vitro analysis of clinically relevant parametersK B Thomas, W Urbancik, P L Turecek, et al.
Journal of Thrombosis and Haemostasis : JTH|May 9, 2009
Species-dependent variability of ADAMTS13-mediated proteolysis of human recombinant von Willebrand factorK Varadi, H Rottensteiner, S Vejda, et al.
Thrombosis and Haemostasis|August 3, 1992
High level expression of active human prothrombin in a vaccinia virus expression systemF G Falkner, P L Turecek, R T MacGillivray, et al.
Pageof 6